Department of Biostatistics and Translational Medicine
Paper
We are excited to announce the publication of our latest paper in collaboration with Professor Dipanjan and Professor Hotamışlıgil labs in the Cell Reports journal (IF 8.8). Congratulations to Jędrzej Chrzanowski, MD, Dominika Michałek, MSc and prof. Wojciech Fendler on this achievement. This study investigates the role of Tudor-interacting repair regulator (TIRR, NUDT16L1), as an […]
We are thrilled to share that our PhD student, Damian Mikulski, M.D., has recently published a groundbreaking article in one of the premier hematology journals, Blood (Impact Factor: 20.3). The paper is titled “Mass Spectrometry-Based Assessment of M-protein in Peripheral Blood During Maintenance Therapy in Multiple Myeloma.” This research highlights the prognostic value of mass […]
We are happy to congratulate our PhD student, Damian Mikulski, M.D., for recently published correspondence “MicroRNAs predict early complications of autologous hematopoietic stem cell transplantation” in Biomarker Research! The study focus on autologous hematopoietic stem cell transplantation (AHSCT), specifically examining changes in circulating miRNAs in patients to predict early complications related to the procedure. In […]
We are pleased to share a recent publication coauthored by Dr. Urszula Smyczyńska and Prof. Wojciech Fendler, entitled “Biological basis of extensive pleiotropy between blood traits and cancer risk.” The study offers valuable insights into the genetic basis of complex links between systemic immune cell levels and cancer susceptibility. The findings highlight genomic areas such […]
We are delighted to highlight the recent achievement of our team members: prof. Wojciech Fendler, together with his former PhD student – Beata Małachowska, MD, PhD, a current postdoc at the Department of Radiation Oncology in Albert Einstein College of Medicine (NYC, NY, USA). Their latest work, published in iScience, provides groundbreaking insights into the […]
Despite significant progress in oncology in recent decades, only about 50% of patients with invasive bladder cancer (MIBC) affecting the muscle layer, survive five years after diagnosis. New hope comes from the combination of radiochemotherapy with the rapidly advancing field of immunotherapy. A member of our team, and a specialist in oncological radiotherapy from the […]
Breast cancer is the most common cancer in women. In 2020, 2.3 million new cases were diagnosed, accounting for 11.7% of new cancer diagnoses worldwide. Approximately 5% – 10% of cases involve hereditary breast and ovarian cancer (HBOC), most commonly linked to mutations in the BRCA1 or BRCA2 genes. Currently, BRCA1/2 genetic tests are recommended […]
We are happy to inform about our team member, Dr. Bartłomiej Tomasik, tremendous achievement – the co-discovery of a new DNA repair mechanism. Dr. Bartłomiej Tomasik is a co-author of the article that describes the newly discovered mechanism for repairing double-strand DNA breaks. The work has been published in the prestigious journal ‘Nature Structural & […]
We are pleased to announce that the results of our research in collaboration with Dana Farber Cancer Institute, Maria Skłodowska-Curie National Research Institute of Oncology in Gliwice and Wrocław Medical University have been published in Radiotherapy&Oncology. Our study provides compelling evidence that specific microRNAs in serum can serve as reliable indicators of radiation exposure and […]
We are pleased to announce that the results of our research in collaboration with the Dana-Farber Cancer Institute have been published in Nature Communications! In this publication, we focused on the application of microRNAs for the identification of BRCA1 and BRCA2 gene mutations without DNA sequencing. The developed test does not rely on direct verification […]
